Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1. Reported confirmed VTEC infection cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.

Published byYağmur İncesu Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 1. Reported confirmed VTEC infection cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N."— Presentation transcript:

1 Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no, C = case based, · = no report, ASR: age-standardised rate Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

2 Figure 1. Reported confirmed STEC/VTEC infection cases: rate per 100 000 population, EU/EEA, 2014
Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

3 Figure 2. Reported confirmed STEC/VTEC infection cases: rates by age groups and gender, EU/EEA, 2014
Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

4 Figure 3. Reported confirmed STEC/VTEC infection cases by month, EU/EEA, 2014 compared with 2010−2013 Source: Country reports from Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

5 Figure 4. Reported confirmed STEC/VTEC infection cases: trend and case numbers, EU/EEA, 2010−2014
Source: Country reports from Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

6 Table: Shigatoxin/verocytotoxin-producing Escherichia coli infection surveillance systems overview, 2014 Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Shigatoxin/verocytotoxin-producing Escherichia coli infection. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

Download ppt "Table 1. Reported confirmed VTEC infection cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N."

Similar presentations

THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.

THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.
Map - Region 3 Europe.

Map - Region 3 Europe.
Computer Class – Summer 20092/21/2016 3:45 AM European Countries Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Czech.

Computer Class – Summer 20092/21/2016 3:45 AM European Countries Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Czech.
The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.

The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
Table 1. Numbers and rates of TB cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,

Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.

CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
  Surveillance Data reported by Case definition used characteristics

  Surveillance Data reported by Case definition used characteristics
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014

Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014
Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.

Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.
Table 1. Reported confirmed hepatitis A cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION

DISTRIBUTION AUTOMATIC - GENERATION
Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011.

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country
Country 2010 2011 2012 2013 2014 Cases Rate National data Report type

Country Cases Rate National data Report type
Table 1. Reported invasive Haemophilus influenzae cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011 2012 2013 2014 Con­firmed.

Table 1. Reported invasive Haemophilus influenzae cases: number and rate per population, EU/EEA, 2010–2014 Country Con­firmed.
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Similar presentations

Ads by Google